Pricing Log in Create free account

Grace Therapeutics, Inc. (GRCE) vs Instil Bio, Inc. (TIL)

Grace Therapeutics, Inc. and Instil Bio, Inc. are both Biotechnology companies. Grace Therapeutics, Inc. and Instil Bio, Inc. are of similar size ($41.6M and $41.0M). Across the 12 metrics below, Grace Therapeutics, Inc. leads on 6 and Instil Bio, Inc. on 6.

Valuation

Metric GRCE TIL Biotechnology median
P/E n/m n/m 8.50
P/S 163.45 290.45 9.71
P/B 0.68 0.37 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 108.68 401.03 9.21
Earnings yield (62.43%) (75.63%) (33.15%)
Free cash flow yield (31.27%) (110.46%) (25.50%)

Profitability

Metric GRCE TIL Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (36.19%) (25.33%) (56.36%)
Return on assets (33.74%) (14.13%) (48.04%)
Return on invested capital (43.36%) (18.94%) 0.00%

Growth

Metric GRCE TIL Biotechnology median
Revenue growth (TTM) 1,286.81% — 6.02%
EPS growth (last fiscal year) 40.51% 6.06% 30.26%
Revenue growth, 5-year CAGR (22.91%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GRCE TIL Biotechnology median
Debt to equity 0.00 0.79 0.00
Current ratio 11.47 21.67 4.72
Net debt to EBITDA 1.53 (0.11) 0.96

Dividend

Metric GRCE TIL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GRCE TIL Biotechnology median
Market cap 41.02m 41.57m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack